Connection

SHIAW-YIH LIN to Mice

This is a "connection" page, showing publications SHIAW-YIH LIN has written about Mice.
Connection Strength

0.426
  1. Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway. J Immunother Cancer. 2023 10; 11(10).
    View in: PubMed
    Score: 0.053
  2. Mechanisms of immunogenic cell death and immune checkpoint blockade therapy. Kaohsiung J Med Sci. 2021 Jun; 37(6):448-458.
    View in: PubMed
    Score: 0.044
  3. mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer. Clin Cancer Res. 2016 Apr 01; 22(7):1699-712.
    View in: PubMed
    Score: 0.031
  4. Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure. Cell Cycle. 2015; 14(14):2323-32.
    View in: PubMed
    Score: 0.029
  5. TUSC4 functions as a tumor suppressor by regulating BRCA1 stability. Cancer Res. 2015 Jan 15; 75(2):378-86.
    View in: PubMed
    Score: 0.029
  6. Monoubiquitination of H2AX protein regulates DNA damage response signaling. J Biol Chem. 2011 Aug 12; 286(32):28599-607.
    View in: PubMed
    Score: 0.023
  7. Multiple roles of BRIT1/MCPH1 in DNA damage response, DNA repair, and cancer suppression. Yonsei Med J. 2010 May; 51(3):295-301.
    View in: PubMed
    Score: 0.021
  8. BRIT1/MCPH1 is essential for mitotic and meiotic recombination DNA repair and maintaining genomic stability in mice. PLoS Genet. 2010 Jan 22; 6(1):e1000826.
    View in: PubMed
    Score: 0.021
  9. Exploring Rak tyrosine kinase function in breast cancer. Cell Cycle. 2009 Aug; 8(15):2360-4.
    View in: PubMed
    Score: 0.020
  10. Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell. 2009 Apr 07; 15(4):304-14.
    View in: PubMed
    Score: 0.019
  11. A stability indicating LC-MS/MS method for quantification of a NOX Inhibitor R14 in its bisulfite adduct form for pharmacokinetic studies. J Pharm Biomed Anal. 2023 May 10; 228:115326.
    View in: PubMed
    Score: 0.013
  12. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol. 2001 Sep; 3(9):802-8.
    View in: PubMed
    Score: 0.012
  13. Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress. Mol Cancer Ther. 2021 07; 20(7):1257-1269.
    View in: PubMed
    Score: 0.011
  14. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020 05 01; 11(1):2135.
    View in: PubMed
    Score: 0.010
  15. PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer. Int J Cancer. 2019 03 01; 144(5):1092-1103.
    View in: PubMed
    Score: 0.009
  16. Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers. Nat Commun. 2018 04 03; 9(1):1317.
    View in: PubMed
    Score: 0.009
  17. Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Sci Transl Med. 2017 05 31; 9(392).
    View in: PubMed
    Score: 0.009
  18. MicroPET/CT Imaging of AXL Downregulation by HSP90 Inhibition in Triple-Negative Breast Cancer. Contrast Media Mol Imaging. 2017; 2017:1686525.
    View in: PubMed
    Score: 0.009
  19. A murine preclinical syngeneic transplantation model for breast cancer precision medicine. Sci Adv. 2017 Apr; 3(4):e1600957.
    View in: PubMed
    Score: 0.009
  20. Mcph1/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model. Oncogene. 2015 Aug 13; 34(33):4368-78.
    View in: PubMed
    Score: 0.007
  21. Nucleostemin deletion reveals an essential mechanism that maintains the genomic stability of stem and progenitor cells. Proc Natl Acad Sci U S A. 2013 Jul 09; 110(28):11415-20.
    View in: PubMed
    Score: 0.007
  22. FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis. 2012 Oct; 33(10):1843-53.
    View in: PubMed
    Score: 0.006
  23. siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model. PLoS One. 2010 Sep 20; 5(9):e12860.
    View in: PubMed
    Score: 0.005
  24. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair. Oncogene. 2010 Nov 18; 29(46):6125-37.
    View in: PubMed
    Score: 0.005
  25. Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases. Br J Cancer. 2010 Feb 16; 102(4):774-82.
    View in: PubMed
    Score: 0.005
  26. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma. Cancer Res. 2003 Jul 01; 63(13):3593-7.
    View in: PubMed
    Score: 0.003
  27. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J Biol Chem. 2000 Mar 17; 275(11):8027-31.
    View in: PubMed
    Score: 0.003
  28. Growth/cell cycle regulation of Sp1 phosphorylation. J Biol Chem. 1999 Jan 15; 274(3):1207-15.
    View in: PubMed
    Score: 0.002
  29. Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor. J Biol Chem. 1997 Jul 25; 272(30):18656-65.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.